Quick Answer
Ernexa Therapeutics Inc. reported Long Term Debt of $532.0 thousand for the year ending 2020.
- This data is from Ernexa Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2021.
- XBRL data for this metric is available from 2020 to 2020 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $1.63 million | Q3 2020: $1.63 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: